查看購物車
  • Simplified Chinese
  • English
  • Japanese
  • Korean
封面
市場調查報告書
商品編碼
1598784

上游生物加工市場：按產品、工作流程、使用類型和模式 - 2025-2030 年全球預測

Upstream Bioprocessing Market by Product (Bags & Containers, Bioreactors & Fermenters, Bioreactors Accessories), Workflow (Cell Culture, Cell Separation, Media Preparation), Use Type, Mode - Global Forecast 2025-2030
出版日期: | 出版商: 360iResearch | 英文 180 Pages | 商品交期: 最快1-2個工作天內

價格

※ 本網頁內容可能與最新版本有所差異。詳細情況請與我們聯繫。

2023年上游生物加工市場估值為107億美元，預計2024年將達120.9億美元，複合年成長率為13.54%，到2030年將達260.3億美元。

上游生物加工涵蓋生物技術的早期階段，其中培養和操縱細菌、酵母和哺乳動物細胞等生物體以生產所需的生物物質。此應用對於生物製藥、疫苗、生質燃料和酵素的生產至關重要。我們需要最佳化細胞生長條件，確保所需產品的高產量和高品質，並滿足對生物療法藥物日益成長的需求。最終用途領域包括製藥和生物技術公司、研究機構和受託製造廠商。該領域的成長是由基因工程的進步、慢性病的流行以及個人化醫療的擴展所推動的。新興趨勢包括自動化和流程分析的整合，以提高效率和擴充性，從而提供巨大的成長機會。為了抓住這些機會，鼓勵公司投資先進的反應器技術和上游處理系統，以實現即時監控和控制。然而，高營運成本、複雜的監管要求以及對熟練人員的需求等挑戰可能會阻礙市場成長。此外，還需要可擴展且具成本效益的解決方案，以及製定強力的污染控制措施。解決這些限制需要在更靈活、風險更低的一次性技術和一次性反應器領域持續創新。研究和開發重點還可以致力於改善細胞株開發和代謝工程，以確保提高產品的一致性和產量。市場動態是動態的，其特點是技術的快速進步和對永續實踐的重視。希望利用市場趨勢的公司應優先考慮與學術機構和技術提供者的合作，並強調共同創新以保持競爭優勢。

主要市場統計
基準年[2023] 107億美元
預測年份 [2024] 120.9億美元
預測年份 [2030] 260.3億美元
複合年成長率（%） 13.54%

市場動態：揭示快速發展的上游生物加工市場的關鍵市場洞察

上游生物加工市場正因供需的動態交互作用而轉變。透過了解這些不斷變化的市場動態，公司可以準備好做出明智的投資決策、完善策略決策並抓住新的商機。全面了解這些趨勢可以幫助企業降低政治、地理、技術、社會和經濟領域的風險，同時也能幫助企業了解消費行為及其對製造業的影響。

  • 市場促進因素
    • 對生物治療藥物的需求不斷成長
    • 擴大過程分析技術（PAT）的引進
    • 一次性使用的快速普及
  • 市場限制因素
    • 上游加工設備安裝維護成本高
  • 市場機會
    • 生物相似藥的接受度和核准提高
    • 擴大細胞治療、細胞庫、藥物發現和重組蛋白的上游工程應用
  • 市場挑戰
    • 與標準上游生物過程監測相關的能力限制

波特五力：駕馭上游生物加工市場的策略工具

波特的五力框架是理解市場競爭格局的重要工具。波特的五力框架為評估公司的競爭地位和探索策略機會提供了清晰的方法。該框架可幫助公司評估市場動態並確定新業務的盈利。這些見解使公司能夠利用自己的優勢，解決弱點並避免潛在的挑戰，從而確保更強大的市場地位。

PESTLE分析：了解上游生物加工市場的外部影響

外部宏觀環境因素在塑造上游生物加工市場的績效動態方面發揮著至關重要的作用。對政治、經濟、社會、技術、法律和環境因素的分析提供了應對這些影響所需的資訊。透過調查 PESTLE 因素，公司可以更了解潛在的風險和機會。這種分析可以幫助企業預測法規、消費者偏好和經濟趨勢的變化，並為他們做出積極主動的決策做好準備。

市場佔有率分析 了解上游生物製程市場的競爭格局

對上游生物加工市場的詳細市場佔有率分析可以對供應商績效進行全面評估。公司可以透過比較收益、客戶群和成長率等關鍵指標來揭示其競爭地位。該分析揭示了市場集中、分散和整合的趨勢，為供應商提供了製定策略決策所需的洞察力，使他們能夠在日益激烈的競爭中佔有一席之地。

FPNV 上游生物加工市場中的定位矩陣供應商績效評估

FPNV定位矩陣是評估上游生物加工市場供應商的重要工具。此矩陣允許業務組織根據供應商的商務策略和產品滿意度評估供應商，從而做出符合其目標的明智決策。這四個象限使您能夠清晰、準確地分類供應商，並確定最能滿足您的策略目標的合作夥伴和解決方案。

策略分析與建議繪製上游生物加工市場的成功之路

對於想要加強在全球市場的影響力的公司來說，對上游生物加工市場的策略分析至關重要。透過審查關鍵資源、能力和績效指標，公司可以識別成長機會並努力改進。這種方法使您能夠克服競爭環境中的挑戰，利用新的商機並取得長期成功。

本報告對市場進行了全面分析，涵蓋關鍵重點領域：

1. 市場滲透率：詳細檢視當前市場環境、主要企業的廣泛資料、評估其在市場中的影響力和整體影響力。

2. 市場開拓：辨識新興市場的成長機會，評估現有領域的擴張潛力，並提供未來成長的策略藍圖。

3. 市場多元化：分析近期產品發布、開拓地區、關鍵產業進展、塑造市場的策略投資。

4. 競爭評估與情報：徹底分析競爭格局，檢驗市場佔有率、業務策略、產品系列、認證、監理核准、專利趨勢、主要企業的技術進步等。

5. 產品開發與創新：重點在於有望推動未來市場成長的最尖端科技、研發活動和產品創新。

我們也回答重要問題，幫助相關人員做出明智的決策：

1.目前的市場規模和未來的成長預測是多少？

2. 哪些產品、區隔市場和地區提供最佳投資機會？

3.塑造市場的主要技術趨勢和監管影響是什麼？

4.主要廠商的市場佔有率和競爭地位如何？

5. 推動供應商市場進入和退出策略的收益來源和策略機會是什麼？

目錄

第1章 前言

第2章調查方法

第3章執行摘要

第4章市場概況

第5章市場洞察

  • 市場動態
    • 促進因素
      • 生物製藥需求增加
      • 擴大過程分析技術（PAT）的引進
      • 快速引入一次性上游生物程序
    • 抑制因素
      • 安裝和維護上游處理裝置的成本高昂
    • 機會
      • 生物相似藥的接受度和核准提高
      • 增加上游製程在細胞治療、細胞庫、藥物發現及重組蛋白的應用
    • 任務
      • 與標準上游生物過程監測相關的功能限制
  • 市場區隔分析
  • 波特五力分析
  • PESTEL分析
    • 政治的
    • 經濟
    • 社群
    • 技術的
    • 合法地
    • 環境

第6章上游生物加工市場：依產品

  • 袋子和容器
  • 反應器和發酵罐
  • 反應器配件
  • 細胞培養產品
  • 篩選

第7章上游生物加工市場：依工作流程

  • 細胞培養
  • 細胞分離
  • 媒體準備

第8章上游生物加工市場：依使用類型

  • 多才多藝的
  • 一次性的

第9章上游生物加工市場：依模式

  • 公司內部
  • 外包

第10章美洲上游生物處理市場

  • 阿根廷
  • 巴西
  • 加拿大
  • 墨西哥
  • 美國

第11章亞太上游生物加工市場

  • 澳洲
  • 中國
  • 印度
  • 印尼
  • 日本
  • 馬來西亞
  • 菲律賓
  • 新加坡
  • 韓國
  • 台灣
  • 泰國
  • 越南

第12章歐洲、中東和非洲上游生物加工市場

  • 丹麥
  • 埃及
  • 芬蘭
  • 法國
  • 德國
  • 以色列
  • 義大利
  • 荷蘭
  • 奈及利亞
  • 挪威
  • 波蘭
  • 卡達
  • 俄羅斯
  • 沙烏地阿拉伯
  • 南非
  • 西班牙
  • 瑞典
  • 瑞士
  • 土耳其
  • 阿拉伯聯合大公國
  • 英國

第13章競爭格局

  • 2023 年市場佔有率分析
  • FPNV 定位矩陣，2023
  • 競爭情境分析
  • 戰略分析和建議

公司名單

  • Boehringer Ingelheim International GmbH
  • Danaher Corporation
  • Eppendorf AG
  • Esco Micro Pte. Ltd
  • GE Healthcare
  • Getinge AB
  • High Purity New England
  • Lonza Group AG
  • Meissner Filtration Products, Inc.,
  • Merck KGaA
  • Rentschler Biopharma SE
  • Samsung BioLogics
  • Sartorius AG
  • Tornado Spectral Systems
  • Waters Corporation
Product Code: MRR-A26E0E574508

The Upstream Bioprocessing Market was valued at USD 10.70 billion in 2023, expected to reach USD 12.09 billion in 2024, and is projected to grow at a CAGR of 13.54%, to USD 26.03 billion by 2030.

Upstream bioprocessing encompasses the initial stages of biotechnology where living organisms such as bacteria, yeast, and mammalian cells are cultivated and engineered to produce desired biological materials. The application is critical for producing biopharmaceuticals, vaccines, biofuels, and enzymes. Its necessity lies in optimizing cell growth conditions, ensuring high yield and quality of the target product, and addressing increasing demands for biotherapeutics. End-use sectors include pharmaceutical and biotechnology companies, research institutions, and contract manufacturing organizations. Growth in this field is driven by advancements in genetic engineering, increasing prevalence of chronic diseases, and the expansion of personalized medicine. An emerging trend is the integration of automation and process analytics which enhances efficiency and scalability, offering a significant potential opportunity for growth. To seize these opportunities, companies are advised to invest in advanced bioreactor technologies and upstream processing systems that enable real-time monitoring and control. However, challenges such as high operational costs, complex regulatory requirements, and the need for skilled personnel may impede market growth. Moreover, scalable and cost-effective solutions are necessary, alongside developing robust contamination control measures. To address these limitations, ongoing innovation is required in the areas of disposable technologies and single-use bioreactors, which can offer more flexibility and lower risk. Research and development focus can also pivot towards improving cell line development and metabolic engineering, ensuring better product consistency and yield. The nature of the upstream bioprocessing market is dynamic, characterized by rapid technological advancements and a strong emphasis on sustainable practices. Businesses aiming to capitalize on market trends should prioritize partnerships with academic institutions and technology providers, emphasizing collaborative innovation to maintain competitive advantages.

KEY MARKET STATISTICS
Base Year [2023] USD 10.70 billion
Estimated Year [2024] USD 12.09 billion
Forecast Year [2030] USD 26.03 billion
CAGR (%) 13.54%

Market Dynamics: Unveiling Key Market Insights in the Rapidly Evolving Upstream Bioprocessing Market

The Upstream Bioprocessing Market is undergoing transformative changes driven by a dynamic interplay of supply and demand factors. Understanding these evolving market dynamics prepares business organizations to make informed investment decisions, refine strategic decisions, and seize new opportunities. By gaining a comprehensive view of these trends, business organizations can mitigate various risks across political, geographic, technical, social, and economic domains while also gaining a clearer understanding of consumer behavior and its impact on manufacturing costs and purchasing trends.

  • Market Drivers
    • Rising demand for biotherapeutics
    • Growing implementation of process analytical technology (PAT)
    • Rapid adoption of single-use upstream bioprocessing
  • Market Restraints
    • High cost of establishing and maintaining an upstream processing unit
  • Market Opportunities
    • Increased acceptance and approvals of biosimilars
    • Rising application of upstream process in cell therapy, cell banking, drug discovery, and recombinant proteins
  • Market Challenges
    • Limitations to its capabilities related to standard upstream bioprocess monitoring

Porter's Five Forces: A Strategic Tool for Navigating the Upstream Bioprocessing Market

Porter's five forces framework is a critical tool for understanding the competitive landscape of the Upstream Bioprocessing Market. It offers business organizations with a clear methodology for evaluating their competitive positioning and exploring strategic opportunities. This framework helps businesses assess the power dynamics within the market and determine the profitability of new ventures. With these insights, business organizations can leverage their strengths, address weaknesses, and avoid potential challenges, ensuring a more resilient market positioning.

PESTLE Analysis: Navigating External Influences in the Upstream Bioprocessing Market

External macro-environmental factors play a pivotal role in shaping the performance dynamics of the Upstream Bioprocessing Market. Political, Economic, Social, Technological, Legal, and Environmental factors analysis provides the necessary information to navigate these influences. By examining PESTLE factors, businesses can better understand potential risks and opportunities. This analysis enables business organizations to anticipate changes in regulations, consumer preferences, and economic trends, ensuring they are prepared to make proactive, forward-thinking decisions.

Market Share Analysis: Understanding the Competitive Landscape in the Upstream Bioprocessing Market

A detailed market share analysis in the Upstream Bioprocessing Market provides a comprehensive assessment of vendors' performance. Companies can identify their competitive positioning by comparing key metrics, including revenue, customer base, and growth rates. This analysis highlights market concentration, fragmentation, and trends in consolidation, offering vendors the insights required to make strategic decisions that enhance their position in an increasingly competitive landscape.

FPNV Positioning Matrix: Evaluating Vendors' Performance in the Upstream Bioprocessing Market

The Forefront, Pathfinder, Niche, Vital (FPNV) Positioning Matrix is a critical tool for evaluating vendors within the Upstream Bioprocessing Market. This matrix enables business organizations to make well-informed decisions that align with their goals by assessing vendors based on their business strategy and product satisfaction. The four quadrants provide a clear and precise segmentation of vendors, helping users identify the right partners and solutions that best fit their strategic objectives.

Strategy Analysis & Recommendation: Charting a Path to Success in the Upstream Bioprocessing Market

A strategic analysis of the Upstream Bioprocessing Market is essential for businesses looking to strengthen their global market presence. By reviewing key resources, capabilities, and performance indicators, business organizations can identify growth opportunities and work toward improvement. This approach helps businesses navigate challenges in the competitive landscape and ensures they are well-positioned to capitalize on newer opportunities and drive long-term success.

Key Company Profiles

The report delves into recent significant developments in the Upstream Bioprocessing Market, highlighting leading vendors and their innovative profiles. These include Boehringer Ingelheim International GmbH, Danaher Corporation, Eppendorf AG, Esco Micro Pte. Ltd, GE Healthcare, Getinge AB, High Purity New England, Lonza Group AG, Meissner Filtration Products, Inc.,, Merck KGaA, Rentschler Biopharma SE, Samsung BioLogics, Sartorius AG, Tornado Spectral Systems, and Waters Corporation.

Market Segmentation & Coverage

This research report categorizes the Upstream Bioprocessing Market to forecast the revenues and analyze trends in each of the following sub-markets:

  • Based on Product, market is studied across Bags & Containers, Bioreactors & Fermenters, Bioreactors Accessories, Cell Culture Products, and Filters.
  • Based on Workflow, market is studied across Cell Culture, Cell Separation, and Media Preparation.
  • Based on Use Type, market is studied across Multi-Use and Single-Use.
  • Based on Mode, market is studied across In-House and Outsourced.
  • Based on Region, market is studied across Americas, Asia-Pacific, and Europe, Middle East & Africa. The Americas is further studied across Argentina, Brazil, Canada, Mexico, and United States. The United States is further studied across California, Florida, Illinois, New York, Ohio, Pennsylvania, and Texas. The Asia-Pacific is further studied across Australia, China, India, Indonesia, Japan, Malaysia, Philippines, Singapore, South Korea, Taiwan, Thailand, and Vietnam. The Europe, Middle East & Africa is further studied across Denmark, Egypt, Finland, France, Germany, Israel, Italy, Netherlands, Nigeria, Norway, Poland, Qatar, Russia, Saudi Arabia, South Africa, Spain, Sweden, Switzerland, Turkey, United Arab Emirates, and United Kingdom.

The report offers a comprehensive analysis of the market, covering key focus areas:

1. Market Penetration: A detailed review of the current market environment, including extensive data from top industry players, evaluating their market reach and overall influence.

2. Market Development: Identifies growth opportunities in emerging markets and assesses expansion potential in established sectors, providing a strategic roadmap for future growth.

3. Market Diversification: Analyzes recent product launches, untapped geographic regions, major industry advancements, and strategic investments reshaping the market.

4. Competitive Assessment & Intelligence: Provides a thorough analysis of the competitive landscape, examining market share, business strategies, product portfolios, certifications, regulatory approvals, patent trends, and technological advancements of key players.

5. Product Development & Innovation: Highlights cutting-edge technologies, R&D activities, and product innovations expected to drive future market growth.

The report also answers critical questions to aid stakeholders in making informed decisions:

1. What is the current market size, and what is the forecasted growth?

2. Which products, segments, and regions offer the best investment opportunities?

3. What are the key technology trends and regulatory influences shaping the market?

4. How do leading vendors rank in terms of market share and competitive positioning?

5. What revenue sources and strategic opportunities drive vendors' market entry or exit strategies?

Table of Contents

1. Preface

  • 1.1. Objectives of the Study
  • 1.2. Market Segmentation & Coverage
  • 1.3. Years Considered for the Study
  • 1.4. Currency & Pricing
  • 1.5. Language
  • 1.6. Stakeholders

2. Research Methodology

  • 2.1. Define: Research Objective
  • 2.2. Determine: Research Design
  • 2.3. Prepare: Research Instrument
  • 2.4. Collect: Data Source
  • 2.5. Analyze: Data Interpretation
  • 2.6. Formulate: Data Verification
  • 2.7. Publish: Research Report
  • 2.8. Repeat: Report Update

3. Executive Summary

4. Market Overview

5. Market Insights

  • 5.1. Market Dynamics
    • 5.1.1. Drivers
      • 5.1.1.1. Rising demand for biotherapeutics
      • 5.1.1.2. Growing implementation of process analytical technology (PAT)
      • 5.1.1.3. Rapid adoption of single-use upstream bioprocessing
    • 5.1.2. Restraints
      • 5.1.2.1. High cost of establishing and maintaining an upstream processing unit
    • 5.1.3. Opportunities
      • 5.1.3.1. Increased acceptance and approvals of biosimilars
      • 5.1.3.2. Rising application of upstream process in cell therapy, cell banking, drug discovery, and recombinant proteins
    • 5.1.4. Challenges
      • 5.1.4.1. Limitations to its capabilities related to standard upstream bioprocess monitoring
  • 5.2. Market Segmentation Analysis
  • 5.3. Porter's Five Forces Analysis
    • 5.3.1. Threat of New Entrants
    • 5.3.2. Threat of Substitutes
    • 5.3.3. Bargaining Power of Customers
    • 5.3.4. Bargaining Power of Suppliers
    • 5.3.5. Industry Rivalry
  • 5.4. PESTLE Analysis
    • 5.4.1. Political
    • 5.4.2. Economic
    • 5.4.3. Social
    • 5.4.4. Technological
    • 5.4.5. Legal
    • 5.4.6. Environmental

6. Upstream Bioprocessing Market, by Product

  • 6.1. Introduction
  • 6.2. Bags & Containers
  • 6.3. Bioreactors & Fermenters
  • 6.4. Bioreactors Accessories
  • 6.5. Cell Culture Products
  • 6.6. Filters

7. Upstream Bioprocessing Market, by Workflow

  • 7.1. Introduction
  • 7.2. Cell Culture
  • 7.3. Cell Separation
  • 7.4. Media Preparation

8. Upstream Bioprocessing Market, by Use Type

  • 8.1. Introduction
  • 8.2. Multi-Use
  • 8.3. Single-Use

9. Upstream Bioprocessing Market, by Mode

  • 9.1. Introduction
  • 9.2. In-House
  • 9.3. Outsourced

10. Americas Upstream Bioprocessing Market

  • 10.1. Introduction
  • 10.2. Argentina
  • 10.3. Brazil
  • 10.4. Canada
  • 10.5. Mexico
  • 10.6. United States

11. Asia-Pacific Upstream Bioprocessing Market

  • 11.1. Introduction
  • 11.2. Australia
  • 11.3. China
  • 11.4. India
  • 11.5. Indonesia
  • 11.6. Japan
  • 11.7. Malaysia
  • 11.8. Philippines
  • 11.9. Singapore
  • 11.10. South Korea
  • 11.11. Taiwan
  • 11.12. Thailand
  • 11.13. Vietnam

12. Europe, Middle East & Africa Upstream Bioprocessing Market

  • 12.1. Introduction
  • 12.2. Denmark
  • 12.3. Egypt
  • 12.4. Finland
  • 12.5. France
  • 12.6. Germany
  • 12.7. Israel
  • 12.8. Italy
  • 12.9. Netherlands
  • 12.10. Nigeria
  • 12.11. Norway
  • 12.12. Poland
  • 12.13. Qatar
  • 12.14. Russia
  • 12.15. Saudi Arabia
  • 12.16. South Africa
  • 12.17. Spain
  • 12.18. Sweden
  • 12.19. Switzerland
  • 12.20. Turkey
  • 12.21. United Arab Emirates
  • 12.22. United Kingdom

13. Competitive Landscape

  • 13.1. Market Share Analysis, 2023
  • 13.2. FPNV Positioning Matrix, 2023
  • 13.3. Competitive Scenario Analysis
  • 13.4. Strategy Analysis & Recommendation

Companies Mentioned

  • 1. Boehringer Ingelheim International GmbH
  • 2. Danaher Corporation
  • 3. Eppendorf AG
  • 4. Esco Micro Pte. Ltd
  • 5. GE Healthcare
  • 6. Getinge AB
  • 7. High Purity New England
  • 8. Lonza Group AG
  • 9. Meissner Filtration Products, Inc.,
  • 10. Merck KGaA
  • 11. Rentschler Biopharma SE
  • 12. Samsung BioLogics
  • 13. Sartorius AG
  • 14. Tornado Spectral Systems
  • 15. Waters Corporation

LIST OF FIGURES

  • FIGURE 1. UPSTREAM BIOPROCESSING MARKET RESEARCH PROCESS
  • FIGURE 2. UPSTREAM BIOPROCESSING MARKET SIZE, 2023 VS 2030
  • FIGURE 3. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
  • FIGURE 4. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY REGION, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 5. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 6. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2030 (%)
  • FIGURE 7. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 8. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2023 VS 2030 (%)
  • FIGURE 9. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 10. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2023 VS 2030 (%)
  • FIGURE 11. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 12. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2023 VS 2030 (%)
  • FIGURE 13. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 14. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 15. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 16. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2030 (%)
  • FIGURE 17. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 18. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 19. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 20. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2030 (%)
  • FIGURE 21. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2023 VS 2024 VS 2030 (USD MILLION)
  • FIGURE 22. UPSTREAM BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2023
  • FIGURE 23. UPSTREAM BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2023

LIST OF TABLES

  • TABLE 1. UPSTREAM BIOPROCESSING MARKET SEGMENTATION & COVERAGE
  • TABLE 2. UNITED STATES DOLLAR EXCHANGE RATE, 2018-2023
  • TABLE 3. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, 2018-2030 (USD MILLION)
  • TABLE 4. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 5. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 6. UPSTREAM BIOPROCESSING MARKET DYNAMICS
  • TABLE 7. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 8. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY BAGS & CONTAINERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 9. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY BIOREACTORS & FERMENTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 10. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY BIOREACTORS ACCESSORIES, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 11. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL CULTURE PRODUCTS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 12. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY FILTERS, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 13. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 14. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL CULTURE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 15. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY CELL SEPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 16. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MEDIA PREPARATION, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 17. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 18. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MULTI-USE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 19. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY SINGLE-USE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 20. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 21. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY IN-HOUSE, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 22. GLOBAL UPSTREAM BIOPROCESSING MARKET SIZE, BY OUTSOURCED, BY REGION, 2018-2030 (USD MILLION)
  • TABLE 23. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 24. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 25. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 26. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 27. AMERICAS UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 28. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 29. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 30. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 31. ARGENTINA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 32. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 33. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 34. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 35. BRAZIL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 36. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 37. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 38. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 39. CANADA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 40. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 41. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 42. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 43. MEXICO UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 44. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 45. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 46. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 47. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 48. UNITED STATES UPSTREAM BIOPROCESSING MARKET SIZE, BY STATE, 2018-2030 (USD MILLION)
  • TABLE 49. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 50. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 51. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 52. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 53. ASIA-PACIFIC UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 54. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 55. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 56. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 57. AUSTRALIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 58. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 59. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 60. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 61. CHINA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 62. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 63. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 64. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 65. INDIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 66. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 67. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 68. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 69. INDONESIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 70. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 71. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 72. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 73. JAPAN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 74. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 75. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 76. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 77. MALAYSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 78. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 79. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 80. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 81. PHILIPPINES UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 82. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 83. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 84. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 85. SINGAPORE UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 86. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 87. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 88. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 89. SOUTH KOREA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 90. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 91. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 92. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 93. TAIWAN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 94. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 95. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 96. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 97. THAILAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 98. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 99. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 100. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 101. VIETNAM UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 102. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 103. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 104. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 105. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 106. EUROPE, MIDDLE EAST & AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY COUNTRY, 2018-2030 (USD MILLION)
  • TABLE 107. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 108. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 109. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 110. DENMARK UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 111. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 112. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 113. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 114. EGYPT UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 115. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 116. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 117. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 118. FINLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 119. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 120. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 121. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 122. FRANCE UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 123. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 124. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 125. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 126. GERMANY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 127. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 128. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 129. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 130. ISRAEL UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 131. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 132. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 133. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 134. ITALY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 135. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 136. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 137. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 138. NETHERLANDS UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 139. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 140. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 141. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 142. NIGERIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 143. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 144. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 145. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 146. NORWAY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 147. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 148. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 149. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 150. POLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 151. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 152. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 153. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 154. QATAR UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 155. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 156. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 157. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 158. RUSSIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 159. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 160. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 161. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 162. SAUDI ARABIA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 163. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 164. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 165. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 166. SOUTH AFRICA UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 167. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 168. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 169. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 170. SPAIN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 171. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 172. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 173. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 174. SWEDEN UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 175. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 176. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 177. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 178. SWITZERLAND UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 179. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 180. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 181. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 182. TURKEY UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 183. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 184. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 185. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 186. UNITED ARAB EMIRATES UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 187. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY PRODUCT, 2018-2030 (USD MILLION)
  • TABLE 188. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY WORKFLOW, 2018-2030 (USD MILLION)
  • TABLE 189. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY USE TYPE, 2018-2030 (USD MILLION)
  • TABLE 190. UNITED KINGDOM UPSTREAM BIOPROCESSING MARKET SIZE, BY MODE, 2018-2030 (USD MILLION)
  • TABLE 191. UPSTREAM BIOPROCESSING MARKET SHARE, BY KEY PLAYER, 2023
  • TABLE 192. UPSTREAM BIOPROCESSING MARKET, FPNV POSITIONING MATRIX, 2023